4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0002036798-26-000004
President and CEO sold 11,656 shares at $1.45 ($16,901)
From the SEC's structured data for this filing
Trades in this filing
ALEXANDER MARGARET A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-23 | Sale : show line 1 in the form | −11,656 | $1.45 | $16,901 | 61,750 | D |
| Open-market sales · 11,656 sh · avg $1.45 · $16,901 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-26 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +1,435,000 | 1,435,000 | D |
Loading xslF345X05/form4-03022026_040303.xml…